Biogen Inc. (NASDAQ:BIIB) has scheduled a conference call for 21st October 2020 at 8:00 AM Eastern Time to announce its 3Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.biogen.com
Earnings Expectation
Biogen Inc. is set to announce third quarter earning results on Wednesday 21st October 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, BIIB to report 3Q20 income of $ 8.13 per share. For the full year, analysts anticipate top line of $ 13833.70 million, while looking forward to income of $ 34.77 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 13800.00 million ~ $ 14200.00 million, where as bottomline are predicted in a range of $ 34.00 ~ $ 36.00 per share
Click Here For More Historical Outlooks Of Biogen Inc.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis (MS); SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of plaque psoriasis.
